Clinical trial Recruiting at 1 site Observational Ages 18 and up

Early PD signals in people with REM sleep behavior disorder

Official title: A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD

Run by Danish Research Centre for Magnetic Resonance · NCT07790744 · Data updated 2026-11-12

This study tests whether people with REM sleep behavior disorder show early signs of Parkinson’s disease before classic symptoms appear.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorDanish Research Centre for Magnetic Resonance
Academic / other
Locations1 site (Hvidovre)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedJune 30, 2028
Study endsDecember 31, 2035
Registry record updatedAugust 27, 2026
Trial IDNCT07790744 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with confirmed REM sleep behavior disorder and no major neurological or psychiatric conditions, plus a matched healthy control group.

Probably not a fit

Patients with significant comorbidities or implanted devices may not be suitable and may receive limited indirect benefits from broader knowledge.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to deeply characterize early-stage Parkinson’s disease in individuals with REM sleep behavior disorder using multimodal assessments. Participants may undergo advanced imaging and noninvasive evaluations to identify biomarkers and non-motor symptoms that precede motor PD. The research team includes the Danish Research Centre for Magnetic Resonance and collaborators at Danish Sleep Medicine centers, with a focus on understanding prodromal PD trajectories. Enrollment includes adults with verified RBD and age-matched healthy controls, who can provide informed consent. The goal is to improve early detection and inform future interventions for synucleinopathies.

Why it matters

Potential benefit: If successful, the study could improve understanding of early PD markers and guide earlier, more targeted interventions.

How similar studies have gone: Prior work in prodromal PD and RBD cohorts has shown promise in identifying early biomarkers, but this area remains exploratory and evolving.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Both groups - The ability to give informed consent

For RBD-group

* Verified REM-sleep behaviour disorder via polysonography
* No other significant neurological and psychiatric ilness

For Healthy controls

\- Age matched to RBD-group

Exclusion Criteria:

* Ferrous objects in or around the body
* Pacemaker or other implanted electronic devices
* Drug abuse unrelated to medication or alcohol abuse over a period of 6 months prior to the experiment
* Other major immunological, cardiac, neurological or neuropsychiatric disorders
* Claustrophobia
* Incapability of giving informed consent
* Unwillingness to be informed about abnormal findings.
* Participation in clinical trials involving drug testing over a period of 6 months prior to the experiment.
* Disease symptoms leading to excessive movement inside the scanner (e.g., excessive tremor)

Where it's running

  • Danish Research Centre for Magnetic Resonance
    Hvidovre, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.